ENTITY

Ionetix (IONTX US)

3
Analysis
Health Care • United States
Ionetix Corporation develops superconducting cyclotron technology for medical and industrial applications. The company generates revenue from diagnostic radioisotopes, such as PET imaging isotopes F-18, Ga-68, and N-13, and therapeutic alpha-emitting isotopes like Ac-225 and At-211, while also exploring other applications for its particle accelerator technology.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x